Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Regulation of Metabolism01:19

Regulation of Metabolism

11.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
11.4K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

1.9K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

524
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
524
Bioavailability: Influencing Factors01:22

Bioavailability: Influencing Factors

342
Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
342
Cancer Prevention02:59

Cancer Prevention

7.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Pangenome-based human genome analysis improves trait association and genomic prediction.

bioRxiv : the preprint server for biology·2026
Same author

Ubiquitin-like proteins NEDD8 and SUMO2 control epithelial homeostasis, regeneration, and inflammation.

Science (New York, N.Y.)·2026
Same author

Population-scale detection of methylation outliers from long-read genome sequencing.

medRxiv : the preprint server for health sciences·2026
Same author

Decoding common and rare noncoding variant effects across cellular and developmental contexts.

Nature genetics·2026
Same author

Building an Interoperable Rare Disease Multi-omic Resource: The GREGoR Data Model and Dataset.

bioRxiv : the preprint server for biology·2026
Same author

Publisher Correction: The impact of exercise on gene regulation in association with complex trait genetics.

Nature communications·2026

相关实验视频

Updated: Jan 17, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.2K

饮食代谢物与人类结肠癌的调控风险变体之间的相互作用

Tania N Fabo1,2, Robin M Meyers1,2, Evin Padhi3

  • 1Program in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, USA.

bioRxiv : the preprint server for biology
|September 18, 2025
PubMed
概括

饮食代谢物如丁酸盐和脱氧胆酸与遗传变异相互作用,影响结肠直肠癌 (CRC) 风险. 这些相互作用可以改变基因表达,可能导致癌症的发展.

关键词:
癌症 癌症 癌症 癌症饮食 饮食 饮食 饮食我们的环境环境环境环境环境环境环境环境基因调节 基因调节 基因调节

更多相关视频

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.4K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.7K

相关实验视频

Last Updated: Jan 17, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

1.2K
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.4K
Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

12.7K

科学领域:

  • 遗传学 遗传学 是一个
  • 分子生物学分子生物学
  • 癌症研究 癌症研究

背景情况:

  • 非编码DNA中的遗传变异与结直肠癌 (CRC) 易感性有关.
  • 这些调节区域可能与饮食因素相互作用,影响基因表达和癌症风险.

研究的目的:

  • 调查CRC相关的饮食代谢物对调控变异的影响.
  • 确定影响CRC风险的基因环境相互作用 (GxE).

主要方法:

  • 利用大规模并行报告测试 (MPRA) 来测试3703种与CRC相关的变异.
  • 评估了丁酸盐和脱氧胆酸对人类结肠细胞变异性活性的影响.

主要成果:

  • 确定了1595种变种与饮食中的代谢物相互作用.
  • 观察到基因失调,包括MED13L,NKD2和Wnt/β-catenin信号调节器.
  • 发现酸和脱氧胆酸对特定位置的相反作用,涉及FOSL1和SP1.

结论:

  • 饮食代谢物与CRC遗传风险位相互作用,影响基因表达.
  • 这些发现突出了CRC病因学中的潜在基因环境相互作用.
  • MPRA与环境因素相结合,为研究常见癌症中的GxE提供了一种方法.